The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.
Related Posts
Nuclear’s Second Act: Energy Stocks Set to Soar Before 2026
The world is quietly entering a new nuclear age. As electricity demand spikes from AI, EVs, and global manufacturing, countries are…
Netflix to buy Warner Bros Discovery’s studios, streaming unit for $72 billion
By Harshita Mary Varghese and Aditya Soni Dec 5 (Reuters) – Netflix on Friday agreed to buy Warner Bros Discovery’s…
Chevron Reveals $16B Of 2024 Capex Budget
Upstream spending in 2024 is expected to be about $14 billion. Downstream capex is expected to be roughly $1.5 billion, with 80 percent allocated to…